维生素D及其类似物在慢性肾脏病患者中应用的中国实践方案(2019版)

2020-02-20 中国医师协会肾内科医师分会 中华内科杂志.2020,59(2):104-116.

维生素D及其类似物的不足/缺乏在我国普通人群和慢性肾脏病(CKD)患者中广泛存在,维生素D及其类似物亦广泛应用于CKD患者治疗。尽管多个国内外临床实践指南或专家共识对维生素D及其类似物合理应用做出了规

中文标题:

维生素D及其类似物在慢性肾脏病患者中应用的中国实践方案(2019版)

发布日期:

2020-02-20

简要介绍:

维生素D及其类似物的不足/缺乏在我国普通人群和慢性肾脏病(CKD)患者中广泛存在,维生素D及其类似物亦广泛应用于CKD患者治疗。尽管多个国内外临床实践指南或专家共识对维生素D及其类似物合理应用做出了规范,但多为针对某一疾病或并发症,缺乏针对CKD患者维生素D及其类似物的整体指导建议。并且,基于循证医学证据的临床实践指南中,对维生素D及其类似物的药理作用阐述不足,对如何依据CKD患者不同病理生理状态合理选择维生素D及其类似物进行个体化治疗的指导不足。因此,本方案针对CKD诊疗实践中的常见问题,系统介绍了维生素D及其类似物的来源、代谢与分类、药理机制、适应范围、临床检测与管理目标、不同病理生理状态下临床用药选择和治疗方案以及不良反应与注意事项。旨在指导临床医生在CKD诊疗过程中,合理应用维生素D及其类似物,提高临床诊疗水平。并且,随着更多国内外相关研究证据的呈现,本方案将在未来重新修订。

 

下载附件:

(因为版权问题,不支持下载)

评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1183824, encodeId=9c95118382472, content=指导意义比较好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc435475929, createdName=ms1000000861491970, createdTime=Thu Jan 13 10:29:49 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973738, encodeId=c6529e37382e, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51545521313, createdName=学习之人, createdTime=Tue Jun 15 15:00:58 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950856, encodeId=926b950856f5, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60655466918, createdName=ms6000000959415943, createdTime=Wed Mar 24 21:24:18 CST 2021, time=2021-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943996, encodeId=a6b194399690, content=好 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b1a5414814, createdName=ms7000000675961159, createdTime=Sat Feb 27 17:53:48 CST 2021, time=2021-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925115, encodeId=b8c2925115ca, content=挺好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01432550878, createdName=12540703m99暂无昵称, createdTime=Wed Feb 17 20:16:52 CST 2021, time=2021-02-17, status=1, ipAttribution=)]
    2022-01-13 ms1000000861491970

    指导意义比较好

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1183824, encodeId=9c95118382472, content=指导意义比较好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc435475929, createdName=ms1000000861491970, createdTime=Thu Jan 13 10:29:49 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973738, encodeId=c6529e37382e, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51545521313, createdName=学习之人, createdTime=Tue Jun 15 15:00:58 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950856, encodeId=926b950856f5, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60655466918, createdName=ms6000000959415943, createdTime=Wed Mar 24 21:24:18 CST 2021, time=2021-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943996, encodeId=a6b194399690, content=好 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b1a5414814, createdName=ms7000000675961159, createdTime=Sat Feb 27 17:53:48 CST 2021, time=2021-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925115, encodeId=b8c2925115ca, content=挺好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01432550878, createdName=12540703m99暂无昵称, createdTime=Wed Feb 17 20:16:52 CST 2021, time=2021-02-17, status=1, ipAttribution=)]
    2021-06-15 学习之人

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1183824, encodeId=9c95118382472, content=指导意义比较好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc435475929, createdName=ms1000000861491970, createdTime=Thu Jan 13 10:29:49 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973738, encodeId=c6529e37382e, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51545521313, createdName=学习之人, createdTime=Tue Jun 15 15:00:58 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950856, encodeId=926b950856f5, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60655466918, createdName=ms6000000959415943, createdTime=Wed Mar 24 21:24:18 CST 2021, time=2021-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943996, encodeId=a6b194399690, content=好 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b1a5414814, createdName=ms7000000675961159, createdTime=Sat Feb 27 17:53:48 CST 2021, time=2021-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925115, encodeId=b8c2925115ca, content=挺好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01432550878, createdName=12540703m99暂无昵称, createdTime=Wed Feb 17 20:16:52 CST 2021, time=2021-02-17, status=1, ipAttribution=)]
    2021-03-24 ms6000000959415943

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1183824, encodeId=9c95118382472, content=指导意义比较好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc435475929, createdName=ms1000000861491970, createdTime=Thu Jan 13 10:29:49 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973738, encodeId=c6529e37382e, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51545521313, createdName=学习之人, createdTime=Tue Jun 15 15:00:58 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950856, encodeId=926b950856f5, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60655466918, createdName=ms6000000959415943, createdTime=Wed Mar 24 21:24:18 CST 2021, time=2021-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943996, encodeId=a6b194399690, content=好 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b1a5414814, createdName=ms7000000675961159, createdTime=Sat Feb 27 17:53:48 CST 2021, time=2021-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925115, encodeId=b8c2925115ca, content=挺好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01432550878, createdName=12540703m99暂无昵称, createdTime=Wed Feb 17 20:16:52 CST 2021, time=2021-02-17, status=1, ipAttribution=)]
    2021-02-27 ms7000000675961159

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1183824, encodeId=9c95118382472, content=指导意义比较好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fc435475929, createdName=ms1000000861491970, createdTime=Thu Jan 13 10:29:49 CST 2022, time=2022-01-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=973738, encodeId=c6529e37382e, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51545521313, createdName=学习之人, createdTime=Tue Jun 15 15:00:58 CST 2021, time=2021-06-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=950856, encodeId=926b950856f5, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=60655466918, createdName=ms6000000959415943, createdTime=Wed Mar 24 21:24:18 CST 2021, time=2021-03-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=943996, encodeId=a6b194399690, content=好 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=80, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1b1a5414814, createdName=ms7000000675961159, createdTime=Sat Feb 27 17:53:48 CST 2021, time=2021-02-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=925115, encodeId=b8c2925115ca, content=挺好的, beContent=null, objectType=guider, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=01432550878, createdName=12540703m99暂无昵称, createdTime=Wed Feb 17 20:16:52 CST 2021, time=2021-02-17, status=1, ipAttribution=)]
    2021-02-17 12540703m99暂无昵称

    挺好的

    0

拓展阅读

2015慢性肾脏病评估及管理临床实践指南解读——从 K/DOQI 到 KDIGO

国际肾脏病学会(ISN,International Society of Nephrology) · 2016-04-25

慢性肾脏病筛查诊断及防治指南

肾脏病相关专家小组(统称) · 2017-01-30

HIV感染合并慢性肾脏病患者管理专家共识

中国感染病相关专家组(统称) · 2017-06-15